We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.53%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$6.09B
AUM Growth
+$393M
(+6.9%)
Cap. Flow
-$95.1M
Cap. Flow
% of AUM
-1.56%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
956
New
52
Increased
378
Reduced
294
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lazard
LAZ
|
+$10.7M |
| 2 |
QGENF
QIAGEN NV
QGENF
|
+$8.34M |
| 3 |
Cisco
CSCO
|
+$8.11M |
| 4 |
FRC
First Republic Bank
FRC
|
+$7.27M |
| 5 |
Phillips 66
PSX
|
+$6.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$39M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$11.6M |
| 3 |
Target
TGT
|
+$10.9M |
| 4 |
GE Aerospace
GE
|
+$10.3M |
| 5 |
PNC Financial Services
PNC
|
+$8.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.83% |
| 2 | Healthcare | 16% |
| 3 | Technology | 10.83% |
| 4 | Communication Services | 9.48% |
| 5 | Industrials | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGR
401
DELISTED
Aegerion Pharmaceuticals
AEGR
| $1.19M | 0.02% |
16,550
+450
| +3% | +$34.4K |
|
402
Yum! Brands
YUM
$41.1B
| $1.19M | 0.02% |
22,373
-10,085
| -31% | -$519K |
|
403
Huntsman Corp
HUN
$1.77B
| $1.19M | 0.02% |
48,800
-600
| -1% | -$13.7K |
|
404
Unum
UNM
$14.3B
| $1.19M | 0.02% |
33,817
-3,604
| -10% | -$118K |
|
|
XEC
405
DELISTED
CIMAREX ENERGY CO
XEC
| $1.18M | 0.02% |
11,346
+2,481
| +28% | +$251K |
|
|
OCR
406
DELISTED
OMNICARE INC
OCR
| $1.17M | 0.02% |
19,425
-3,400
| -15% | -$195K |
|
|
GEVA
407
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $1.16M | 0.02% |
17,500
+2,300
| +15% | +$137K |
|
408
Manulife Financial
MFC
$73.5B
| $1.15M | 0.02% |
58,400
-7,543
| -11% | -$138K |
|
|
FDO
409
DELISTED
FAMILY DOLLAR STORES
FDO
| $1.15M | 0.02% |
17,623
+17,080
| +3,145% | +$1.17M |
|
|
CLVS
410
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.14M | 0.02% |
19,350
+2,500
| +15% | +$136K |
|
411
Globe Life
GL
$14.3B
| $1.13M | 0.02% |
21,722
+1,365
| +7% | +$68.1K |
|
|
SNDK
412
DELISTED
SANDISK CORP
SNDK
| $1.13M | 0.02% |
16,128
+5,327
| +49% | +$359K |
|
413
Everest Group
EG
$14.4B
| $1.13M | 0.02% |
7,354
+6,472
| +734% | +$988K |
|
|
GPOR
414
DELISTED
Gulfport Energy Corp.
GPOR
| $1.13M | 0.02% |
18,386
| – | – |
|
|
GTAT
415
DELISTED
GT ADVANCED TECHNOLOGIES INC COM STK (DE)
GTAT
| $1.11M | 0.02% |
126,700
-69,000
| -35% | -$613K |
|
|
JNPR
416
DELISTED
Juniper Networks
JNPR
| $1.11M | 0.02% |
50,300
-3,500
| -7% | -$71K |
|
417
Campbell Soup
CPB
$6.87B
| $1.09M | 0.02% |
25,292
-359
| -1% | -$14.9K |
|
418
Avnet
AVT
$7.92B
| $1.09M | 0.02% |
25,083
-300
| -1% | -$12.4K |
|
419
MannKind Corp
MNKD
$1.32B
| $1.08M | 0.02% |
40,660
+8,200
| +25% | +$208K |
|
420
Celldex Therapeutics
CLDX
$3.28B
| $1.08M | 0.02% |
3,073
+60
| +2% | +$23.1K |
|
|
ICON
421
DELISTED
Iconix Brand Group, Inc.
ICON
| $1.08M | 0.02% |
2,710
-70
| -3% | -$25.8K |
|
|
SWY
422
DELISTED
SAFEWAY INC
SWY
| $1.07M | 0.02% |
36,978
-16,252
| -31% | -$488K |
|
423
Agnico Eagle Mines
AEM
$90.5B
| $1.07M | 0.02% |
41,436
-15,030
| -27% | -$404K |
|
424
Pacira BioSciences
PCRX
$997M
| $1.07M | 0.02% |
19,000
+500
| +3% | +$26.3K |
|
425
Dillards
DDS
$9.56B
| $1.05M | 0.02% |
10,900
+2,500
| +30% | +$216K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2013 Portfolio in Review
As of Q4 2013, DekaBank Deutsche Girozentrale held 956 positions worth $6.09B, up 6.9% from $5.69B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
DekaBank Deutsche Girozentrale's Q4 2013 filing shows 52 new, 378 increased, 294 reduced and 42 closed positions. Its largest new stake was Lazard: 264,565 shares worth $11.9M. The largest sale was Deutsche Bank, an estimated $39M.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Technology.
- DekaBank Deutsche Girozentrale's largest Q4 2013 buy was Lazard: 264,565 shares worth $11.9M.
- DekaBank Deutsche Girozentrale added most to QIAGEN NV in Q4 2013, an estimated $8.34M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2013 reduction was Deutsche Bank, cutting an estimated $39M.
- DekaBank Deutsche Girozentrale fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $5.92M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 33% of its $6.09B portfolio in Q4 2013.
- DekaBank Deutsche Girozentrale opened 52 new positions and closed 42 in Q4 2013.
- DekaBank Deutsche Girozentrale's portfolio value rose 6.9% quarter-over-quarter to $6.09B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2013, filed 11 Feb 2014.